Abstract
Multimodal imaging-guided photothermal therapy (PTT), for the therapy of cancer, based on a ferritin (FRT) nanocage loaded with the near-infrared dye IR820 (designated DFRT) is demonstrated. The dual roles of DFRT (in imaging and PTT) are successfully balanced by using two different excitation wavelengths: 550 nm for high quantum-yield fluorescence imaging on the one hand and 808 nm for photoacoustic imaging and PTT with high photothermal conversion efficiency on the other.
Keywords:
ferritin; fluorescence imaging; photoacoustic imaging; photothermal therapy; theranostics.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Publication types
-
Research Support, N.I.H., Intramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Cell Line, Tumor
-
Ferritins / chemistry*
-
Fluorescent Dyes / chemistry*
-
Indocyanine Green / chemistry
-
Lasers
-
Mice
-
Microscopy, Atomic Force
-
Microscopy, Fluorescence
-
Nanostructures / chemistry*
-
Neoplasms / diagnostic imaging
-
Neoplasms / drug therapy
-
Neoplasms / pathology
-
Oligopeptides / chemistry
-
Particle Size
-
Photochemotherapy
-
Photosensitizing Agents / pharmacokinetics
-
Photosensitizing Agents / therapeutic use
-
Tissue Distribution
-
Transplantation, Homologous
-
Ultrasonography
Substances
-
Fluorescent Dyes
-
Oligopeptides
-
Photosensitizing Agents
-
arginyl-glycyl-aspartic acid
-
Ferritins
-
Indocyanine Green